Caring4Cancer

LONDON (Reuters) - GlaxoSmithKline said on Wednesday new data showed its Cervarix vaccine generated sustained, high levels of neutralizing antibodies against the two most common cervical cancer-causing virus types for 6.4 years.

NEW YORK (Reuters Health) - Telephone counseling may give cervical cancer survivors a boost to their well-being, and possibly their immune function as well, a small study suggests.

WASHINGTON (Reuters) - An unprecedented number of U.S. youngsters are fainting after getting shots, especially teenage girls, and doctors need to keep an eye on them, federal health experts cautioned on Thursday.

NEW YORK (Reuters Health) - Not having had a Pap smear taken within the recommended screening interval was the most important risk factor for advanced cervical cancer observed during an audit of Sweden's cervical cancer screening program.

NEW YORK (Reuters Health) - Many African-American women may overestimate the number of cancer screening tests they have had, potentially putting them at risk of late cancer detection, a small study suggests.

WASHINGTON (Reuters) - Up to 70 percent of British schoolgirls are likely to take up the offer of a vaccine to protect them against cervical cancer, despite doubts about other vaccines, researchers reported on Thursday.

NEW YORK (Reuters Health) - Latinas think they have a higher risk of cancer than women from other ethnic groups, while Asian women have a consistently lower estimation of their cancer risk than women of other races, according to the findings of the first study of how race and ethnicity influences women's perception of cancer risk.

Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in gynecological cancers difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.

NEW YORK (Reuters Health) - A period of "watchful waiting" may be an appropriate strategy for women who initially test positive for a carcinogenic subtype of human papillomavirus (HPV), but who have apparently normal cells in their cervix, new research suggests.

NEW YORK (Reuters Health) - Testing for human papillomavirus (HPV), the cause of most cervical cancers, is more sensitive than the results of conventional cervical tissue analysis, or Pap test, for the detection of cancer, according to the results of an Italian study published in the Journal of the National Cancer Institute. However, this is limited by the fact that HPV infections often resolve among women younger than 35 years of age.

NEW YORK (Reuters Health) - As oncologists become less involved in the care of patients who have survived cancer, cancer-related screening decreases significantly, a study shows.

NEW YORK (Reuters Health) - Obese women, particularly white obese women, are less likely than their thinner peers to be screened for breast and cervical cancers, researchers reported Monday.

The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.

WASHINGTON (Reuters) - There are two distinct culprits behind head and neck cancer -- the long-recognized heavy tobacco and alcohol use as well as a common sexually transmitted virus, researchers said on Tuesday.

WASHINGTON (Reuters) - More than one in four U.S. teen girls is infected with at least one sexually transmitted disease, and the rate is highest among blacks, the U.S. Centers for Disease Control and Prevention said on Tuesday.

SHENZHEN, China (Reuters) - Chinese scientists are trying to find out which errant genes are responsible for diabetes and certain forms of cancer that have long plagued Chinese populations, a geneticist said.

NEW YORK (Reuters Health) - Among women with abnormalities on a Pap test, those who report high levels of daily stress appear to have a weakened immune response to a type of human papillomavirus, HPV16, that can cause cervical cancer.

NEW YORK (Reuters Health) - Women run a significant risk of acquiring human papillomavirus (HPV) from their very first sex partner, according to a new report.

LONDON (Reuters) - The tattoo of the future may be good for your health rather than just your image.

LONDON (Reuters) - New data from a combined analysis of four Phase II/III studies involving more than 20,000 women confirm the effectiveness of Merck & Co Inc's cervical cancer vaccine Gardasil, researchers said on Thursday.

LONDON (Reuters) - Birth control pills can protect women against ovarian cancer for 30 years or longer after they stop taking them and have so far prevented 100,000 ovarian cancer deaths worldwide, British researchers said on Thursday.

NEW YORK (Reuters Health) - Women who beat cervical cancer may continue to have sexual difficulties and other problems that diminish their quality of life, a study shows.

WASHINGTON (Reuters) - Only 2 percent of U.S. adults last year got a shot that can protect them from painful bouts of shingles, health officials said on Wednesday in a study that shows what they call unacceptably low rates of adult vaccination against a range of diseases.

LONDON (Reuters) - The vaccine against the sexually transmitted virus that causes the most cases of cervical cancer is cost-effective and should be given to adolescent girls before they start having sex, an EU agency said on Tuesday.

For the detection of cervical abnormalities, liquid-based cytology does not appear to be more accurate than the conventional Pap test. This was the conclusion of a combined analysis published in the journal Obstetrics and Gynecology.

LONDON (Reuters) - GlaxoSmithKline Plc's cervical cancer vaccine Cervarix faces a delay in winning approval in the United States, putting it further behind Merck & Co Inc's rival product Gardasil, which is already available.

WASHINGTON (Reuters) - About 7.6 million people will die this year worldwide from various types of cancer, with lung cancer -- heavily driven by smoking -- killing 975,000 men and 376,000 women, the American Cancer Society said on Monday.

LONDON (Reuters) - Women could be able to get the contraceptive pill from their chemist without a prescription, a health minister said on Thursday.

According to the results of a study published in the Journal of the American Medical Association, post-treatment imaging with positron emission tomography (PET) may provide important information about response to cervical cancer treatment and likelihood of survival.

NEW YORK (Reuters Health) - Pap smears may provoke a beneficial short-term immune response against sexually transmitted viral infections, South African researchers report.

According to an article recently published in The Lancet, the use of combined oral contraceptives (estrogen and progestin) temporarily increases the risk of cervical cancer.  However, this risk remains small: one extra person per 1,000 is diagnosed with cervical cancer with use of the contraceptives.

CHICAGO (Reuters) - Women who take oral contraceptives run a higher risk of developing cervical cancer, but this risk is transient and reverts to normal about 10 years after they stop, British researchers said on Thursday.

According to the results of a study published in the British Medical Journal, women who have been treated for high-grade precancerous changes to the cervix (cervical intraepithelial neoplasia grade 3) are more likely than women in the general population to subsequently develop cervical or vaginal cancer. Furthermore, this increased risk persists for at least 25 years.

HONG KONG (Reuters) - Cervical cancer is much more common in Asia than the quarter of a million new cases recorded each year, according to an expert, who says governments should consider vaccinating all women because screenings are too costly.

NEW YORK (Reuters Health) - In a study of sexually active young male, heterosexual college students, almost two thirds developed genital human papillomavirus (HPV) infection over 2 years of follow-up, according to Seattle-based researchers.

CHICAGO (Reuters) - Gardasil, Merck's vaccine for preventing cervical cancer in girls and women aged 9 to 26, may offer protection for women up to age 45, the company said on Sunday.

According to the results of a study published in the Journal of the National Cancer Institute, cervical cancer survivors have an increased risk of later developing other types of cancer, particularly if their cervical cancer was treated with radiation therapy. This increased risk persists for more than 40 years after the cervical cancer diagnosis.

NEW YORK (Reuters Health) - Women who survive cervical cancer are at increased risk for developing other cancers decades later, according to a report in the Journal of the National Cancer Institute. The increased cancer risk is primarily seen in women who were treated with radiation therapy and involves organs that lie near the cervix.

LONDON (Reuters Life!) - All girls aged 12 to 13 in England will be vaccinated against the sexually transmitted virus that causes most cervical cancer cases, the government said Friday.

LONDON (Reuters) - Women treated for pre-cancerous lesions are at increased risk of developing cervical or vaginal cancer for at least another 25 years, according to a study suggesting that follow-up tests fall dangerously short.

According to the results of a study published in the New England Journal of Medicine, testing for high-risk types of human papillomavirus (HPV) detects a higher proportion of precancerous changes to the cervix than conventional Pap testing, but also produces more false-positive results. A second study published in the same issue assessed the combination of HPV testing and Pap testing.

BARCELONA (Reuters) - The risk of divorce increases if one partner suffers from testicular or cervical cancer, but other types have no effect on whether a couple stays together, Norwegian researchers said on Thursday.

WASHINGTON (Reuters) - Vitamin C can impede the growth of some types of tumors although not in the way some scientists had suspected, researchers reported on Monday.

According to the results of a study published in the Journal of the American Medical Association, Cervarix™—a vaccine designed to prevent infection with two high-risk types of human papillomavirus (HPV)—does not treat HPV infections in women who are already infected at the time of vaccination.

CHICAGO (Reuters) - Vaccines designed to prevent infection from two strains of the human papillomavirus virus that cause most cases of cervical cancer offer no benefit as a treatment for women who are already infected, U.S. researchers said on Tuesday.

LONDON (Reuters) - Holidaymakers were warned on Thursday to protect themselves in the sun and avoid getting burnt after figures revealed skin cancer has become the fastest growing form of cancer in Britain.

NEW YORK (Reuters Health) - Long-term survivors of vaginal and cervical cancer are as likely as other women to be sexually active, but they have a lot more sex-related problems and these are often not addressed by their doctors, researchers report.

NEW YORK (Reuters Health) - By scheduling a well-child visit for their 11- or 12-year-old, parents can help protect their pre-teen's health into the turbulent teen years and beyond, according to the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP).

According to the results of a study conducted in India, an inexpensive approach to cervical cancer screening produced significant reductions in cervical cancer incidence and mortality. These results were published in the Lancet.

The National Comprehensive Cancer Network (NCCN) has recommended fertility-preserving surgery to include more women with cervical cancer.